Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt’s lymphoma anti-tumor activity-Reference-Cited by-同舟云学术

Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt’s lymphoma anti-tumor activity

Published:2017-05-25 Issue:41 Volume:8 Page:69219-69236
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Curtis Nicola J.¹,Mooney Lorraine¹,Hopcroft Lorna²,Michopoulos Filippos¹,Whalley Nichola²,Zhong Haihong³,Murray Clare⁴⁵,Logie Armelle¹,Revill Mitchell¹,Byth Kate F.⁶,Benjamin Amanda D.⁴,Firth Mike A.¹,Green Stephen¹,Smith Paul D.²,Critchlow Susan E.²

Affiliation:

1. iMED Oncology, AstraZeneca, Alderley Park, Cheshire, UK

2. iMED Oncology, AstraZeneca, Cambridge, UK

3. MedImmune, One MedImmune Way, Gaithersburg, MD, USA

4. iMED DSM, AstraZeneca, Cambridge, UK

5. C4X Discovery, Manchester, UK

6. iMED Oncology, AstraZeneca, Gatehouse Park, Waltham, Massachusetts, MA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lysine lactylation in the regulation of tumor biology;Trends in Endocrinology & Metabolism;2024-08

2. Metabolic profiling and combined therapeutic strategies unveil the cytotoxic potential of selenium-chrysin (SeChry) in NSCLC cells;Bioscience Reports;2024-07

3. Targeting metabolism to enhance immunotherapy within tumor microenvironment;Acta Pharmacologica Sinica;2024-05-29

4. Lactate transport inhibition therapeutically reprograms fibroblast metabolism in experimental pulmonary fibrosis;2024-04-28

5. One-step Radiosynthesis and Preclinical Evaluation of Molecular Probe [18F]FEtO-CHC Targeting Monocarboxylate Transporters for PET Imaging in Tumor-bearing Mice;2024-04-18